Wesbanco Bank Inc Vertex Pharmaceuticals Inc Transaction History

Wesbanco Bank Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$283.23 - $323.1 $7,080 - $8,077	25 Added 1.05%	2,401 $756,000
Q4 2022 Jan 18, 2023	BUY	$285.76 - $321.48 $678,965 - $763,836	2,376 New	2,376 $686,000
Q2 2022 Jul 18, 2022	BUY	$234.96 - $292.55 $563,904 - $702,120	2,400 New	2,400 $676,000
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $1.07 Million - $1.36 Million	-6,065 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$181.39 - $202.99 $1.1 Million - $1.23 Million	6,065 New	6,065 $1.1 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

Stay updated on Wesbanco Bank Inc with notifications on news.